trial · primary record
TAR-210
Non-Muscle Invasive Bladder Neoplasms
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 220 |
| Primary completion | 2032-03-16 |
| Primary endpoint | Disease-free Survival (DFS) |
| Registry ID | NCT06919965 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:54.605Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06919965
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Tar-210 · compound